| Dr Patricia A Nahn, MD | |
|
1000 Mineral Point Ave, Janesville, WI 53548-2940 | |
| (608) 756-6000 | |
| Not Available |
| Full Name | Dr Patricia A Nahn |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 1000 Mineral Point Ave, Janesville, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740348200 | NPI | - | NPPES |
| 32255600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 36855 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health System Corp | Janesville, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health System Corporation | 7416860440 | 459 |
News Archive
Chromcraft, a Division of Chromcraft-Revington, Inc., has been awarded a three year vendor contract starting January 1, 2012 with the Premier healthcare alliance.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
To produce your thoughts and actions, your brain processes information in a hierarchy of regions along its surface, or cortex, ranging from "lower" areas that do basic parsing of incoming sensations to "higher" executive regions that formulate your plans for employing that newfound knowledge
Angiotech Pharmaceuticals, Inc. announced that its partner Cook Medical, Inc. received approval on November 15, 2012 from the U.S. Food and Drug Administration to market and sell the proprietary Zilver PTX drug-eluting peripheral stent, adding the United States to the list of over 50 markets, including the European Union and Japan, where Zilver PTX is approved for sale.
› Verified 6 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031113000164 |
News Archive
Chromcraft, a Division of Chromcraft-Revington, Inc., has been awarded a three year vendor contract starting January 1, 2012 with the Premier healthcare alliance.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
To produce your thoughts and actions, your brain processes information in a hierarchy of regions along its surface, or cortex, ranging from "lower" areas that do basic parsing of incoming sensations to "higher" executive regions that formulate your plans for employing that newfound knowledge
Angiotech Pharmaceuticals, Inc. announced that its partner Cook Medical, Inc. received approval on November 15, 2012 from the U.S. Food and Drug Administration to market and sell the proprietary Zilver PTX drug-eluting peripheral stent, adding the United States to the list of over 50 markets, including the European Union and Japan, where Zilver PTX is approved for sale.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia A Nahn, MD 1000 Mineral Point Ave, Janesville, WI 53548-2940 Ph: (608) 756-6000 | Dr Patricia A Nahn, MD 1000 Mineral Point Ave, Janesville, WI 53548-2940 Ph: (608) 756-6000 |
News Archive
Chromcraft, a Division of Chromcraft-Revington, Inc., has been awarded a three year vendor contract starting January 1, 2012 with the Premier healthcare alliance.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
To produce your thoughts and actions, your brain processes information in a hierarchy of regions along its surface, or cortex, ranging from "lower" areas that do basic parsing of incoming sensations to "higher" executive regions that formulate your plans for employing that newfound knowledge
Angiotech Pharmaceuticals, Inc. announced that its partner Cook Medical, Inc. received approval on November 15, 2012 from the U.S. Food and Drug Administration to market and sell the proprietary Zilver PTX drug-eluting peripheral stent, adding the United States to the list of over 50 markets, including the European Union and Japan, where Zilver PTX is approved for sale.
› Verified 6 days ago
Kay F Johnson-keys, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 E Racine St, Janesville, WI 53546 Phone: 608-373-8000 Fax: 608-371-8928 | |
Tyler Boschuetz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8927 | |
Dr. Kristin L Miller, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 Deerfield Dr, Janesville, WI 53546 Phone: 608-314-3600 Fax: 608-314-3601 | |
Mr. Mark C. Torres, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8928 | |
Dr. Jill M. Cousino, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6800 Fax: 608-756-6236 | |
Noreen R King, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 308-371-8907 | |
Dr. Carol J Neuman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6890 |